These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17157920)

  • 61. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet monoamine oxidase activity in underweight and weight-recovered females with anorexia nervosa.
    Ehrlich S; Franke L; Schott R; Salbach-Andrae H; Pfeiffer E; Lehmkuhl U; Uebelhack R
    Pharmacopsychiatry; 2008 Nov; 41(6):226-31. PubMed ID: 19067259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P; Melamed Y; Weizman A; Bleich A
    Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.
    Gilbert DG; Zuo Y; Browning RA; Shaw TM; Rabinovich NE; Gilbert-Johnson AM; Plath L
    Nicotine Tob Res; 2003 Dec; 5(6):813-9. PubMed ID: 14668065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Late-onset clozapine-induced hypothermia accompanied by electrocardiogram Osborn waves.
    Papazisis G; Tzellos T; Tahmatzidis D; Dolianitis K; Kouvelas D
    J Clin Psychopharmacol; 2009 Apr; 29(2):183-5. PubMed ID: 19512984
    [No Abstract]   [Full Text] [Related]  

  • 69. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 71. Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects.
    Berggren U; Eriksson M; Fahlke C; Blennow K; Balldin J
    Alcohol Alcohol; 2007; 42(3):267-71. PubMed ID: 17526638
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of fenfluramine on neuropsychological and communicative functioning in treatment-refractory schizophrenic patients.
    Soper HV; Elliott RO; Rejzer AA; Marshall BD
    J Clin Psychopharmacol; 1990 Jun; 10(3):168-75. PubMed ID: 2198295
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
    Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effects of sodium oxybutyrate on the level of catecholamines and serotonin and monoamine oxidase activity in patients with alcoholism].
    Treskov VG; Krashkina II; Tsirenina ML; Koltovaia NA; Nikol'skaia GV; Baturin AK; Gapparov MM; Mel'nik EI; Maĭskiĭ AI
    Biull Eksp Biol Med; 1989 Jul; 108(7):62-4. PubMed ID: 2804304
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [About the curability of schizophrenia].
    Gaszner P
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):39-42. PubMed ID: 16167467
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates.
    Anthenelli RM; Smith TL; Craig CE; Tabakoff B; Schuckit MA
    Biol Psychiatry; 1995 Sep; 38(6):361-8. PubMed ID: 8547455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Platelet MAO activity in patients with chronic pain syndrome. Relationship to personality traits, endorphins in CSF and plasma cortisol.
    Johansson F; Von Knorring L; Oreland L
    Med Biol; 1983 Apr; 61(2):101-4. PubMed ID: 6876894
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in schizoaffective patients.
    Joseph MH; Owen F; Baker HF; Bourne RC
    Psychol Med; 1977 Feb; 7(1):159-62. PubMed ID: 859953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.